Join
Live feed
·
INSIDERFilingvia Quantisnow
Mainz Biomed N.V. logo

Director Dreismann Heinrich was granted 45,000 units of Ordinary Shares, increasing direct ownership by 228% to 64,700 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MYNZ· Mainz Biomed N.V.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYNZ (Mainz Biomed N.V.) and more on Quantisnow.